- Forschung
- Karriere
- Aktuelles
- Institut
- Durchsuchen
- Spachumstellung
- Leichte Sprache
„”
The table provides an overview of all disclosed patent applications filed by FVB for FMP technologies:
Title | Publication number | Applicant* | Status |
---|---|---|---|
Inhibitors of NO production | WO2022043465 | MDC, FVB, Charité | Published |
Polyproline mimetics of proline-derived module-15 | WO2019162524 | FVB, Univ zu Köln | Licensed |
1,2,4-triazole derivatives as tankyrase inhibitors | WO2019243822 | Oslo Univ Hospital, FVB, Univ Oulo | Published |
Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors | WO2019234237 | FVB | Published |
Polyproline mimetics of proline-derived module-15 | WO2019162524 | FVB, Univ zu Köln | Licensed |
Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates | WO2019170710 | FVB, LMU | Licensed |
Selective inhibitors of genotoxic stress-induced IKK/NF-kB pathways | WO2018087389 | MDC, FVB | Published |
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates | WO2018041985 | FVB, LMU | Licensed |
Unusual substrates of tubulin tyrosine ligase | WO2017186855 | FVB, LMU | Licensed |
Antagonists of the thyroid-stimulating hormone receptor (TSHR) | WO2017186793 | FVB | Published |
Means and methods for site-specific functionalization of polypeptides | WO2016066749 | LMU, FVB | Licensed |
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same | WO2016135199, WO2018019917 | FVB, MDC | Licensed |
Inhibitors for inhibiting tumor metastasis | WO2016092069 | FVB, Univ zu Köln | Licensed |
Structural mimetics of proline-rich peptides and use thereof | WO2013030111 | FVB, Univ zu Köln | Licensed |
Induction of alpha helix conformations in proteins and peptides | WO2011003626 | Univ zu Köln, FVB | Licensed |
Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists | WO2010047674 | US Health, FVB | Licensed |
Structural mimetics of proline-rich peptides and the pharmaceutical use thereof | WO2008040332 | FVB | Licensed |